| abstract |
The invention relates to different biomarkers of amyotrophic lateral sclerosis (ALS). Various methods using these biomarkers include methods for diagnosing ALS, ALS predisposition methods, SLA progression / regression monitoring methods, efficacy evaluation methods, and methods for determining ALS susceptibility. compositions for treating ALS; methods for screening compositions for ALS biomarker modulation activity; methods for treating ALS; and other methods based on ALS biomarkers. |